Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

This study evaluates the effect of bladder cancer treatment on quality of life.

PRIMARY OBJECTIVES:

I. To compare general and disease-specific quality of life outcomes at 6, 12, 24, and 36 months after treatment for localized bladder cancer using the PROMIS-29 and the Bladder Cancer Index (BCI) respectively.

II. To identify patient level characteristics that may influence quality of life outcomes after treatment for localized bladder cancer.

OUTLINE: This is an observational study.

Patients complete surveys and also have their medical records reviewed on study.

Inclusion Criteria:

• Have pathologically confirmed, clinically localized, bladder cancer
• Be willing to complete a survey in English before starting definitive treatment (surgery or radiation);
• Able to give consent.

Exclusion Criteria:

• Does not meet inclusion criteria